Clinical Trial

Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this observational study is to collect over time a series of data in patients with glaucoma in order to evaluate different approaches in defining the progression of this pathology. These data will be collected in repeated visits over a 36-months follow-up period. At each visit, the COMPASS fundus perimeter and the Humphrey Field Analyzer (HFA) perimeter will be used to assess retinal functionality; an Optical Coherence Tomography (OCT) examination will also be performed to evaluate and obtain clinical information about the structure of the retina.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-04-04; most recent amendment 2025-12-29.
Trial Details
NCT Number NCT05801471
Lead Sponsor Centervue SpA
Conditions Glaucoma
Enrollment 200 participants
Start Date 2022-05-06
Primary Completion 2028-11-06 (estimated)
Study Completion 2028-11-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-02